Dr Reddys Profile

36.55
USD 0.66  1.77%
34.15Last Month High 37.21 
36.08Trading Day  High 37.06 

Dr Reddys Summary

Dr Reddys Laboratories Limited (RDY) is traded on New York Stock Exchange in USA. It is located in INDIA and employs 22,175 people. Dr Reddys is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with total capitalization of 5.77 B. Dr Reddys Laboratories Limited runs under Healthcare sector within Drug Manufacturers - Other industry. This company has 165.83 M outstanding shares of which 3.32 M shares are at this time shorted by investors with about 12.2 days to cover shorted positions. DR. REDDY'S LAB L has about 226.03 M in cash with 224.58 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36.
Check Dr Reddys Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Fisher Asset Management LlcCommon Shares5.5 M195.1 M
Royal Bank Of CanadaCommon Shares3.6 M128.9 M
View Dr Reddys Diagnostics

Dr Reddys Laboratories Risk Profiles

Key Fundamentals

Dr Reddys Against Markets

Current Ratings  

Dr Reddys 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
7 
Chance of
< 16% 
Dr. Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameDr Reddys Laboratories Limited
Analyst Consensus
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock Stocks Directory
LocationINDIA
Business Address, Road No.Hyderabad,
ExchangeNew York Stock Exchange
ISINUS2561352038
CUSIP256135203
SectorHealthcare
IndustryDrug Manufacturers - Other
BenchmarkDOW
Websitewww.drreddys.com
Contact Number91 40 4900 2900
CurrencyUSD - US Dollar

Did you try this?

Run Portfolio Rebalancing Now
   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Hide  View All  NextLaunch Portfolio Rebalancing

Recommendations

Dr Reddys Analyst Recommendations
Target PriceAdvice# of Analysts
48.95Hold2Odds
Dr Reddys Laboratories Limited current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Dr Reddys Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Dr Reddys Earnings Estimates
Dr Reddys Laboratories Limited normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate